Wave Life Sciences Ltd.
WVE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$53,852 | -$50,469 | -$46,878 | $29,253 |
| Dep. & Amort. | $2,230 | $2,196 | $2,164 | $2,156 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,472 | $6,196 | $4,953 | $3,244 |
| Change in WC | $484 | -$3,935 | -$23,278 | -$78,301 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$44,666 | -$46,012 | -$63,039 | -$43,648 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$248 | -$306 | -$165 | -$86 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$248 | -$306 | -$165 | -$86 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $30,212 | $11,099 | $1,262 | $32,945 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,480 | $594 | $2,893 | $2,036 |
| Financing Cash Flow | $32,692 | $11,693 | $4,155 | $34,981 |
| Forex Effect | -$29 | $43 | $58 | -$103 |
| Net Chg. in Cash | -$12,251 | -$34,582 | -$58,991 | -$8,856 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $212,265 | $246,847 | $305,838 | $314,694 |
| End Cash | $200,014 | $212,265 | $246,847 | $305,838 |
| Free Cash Flow | -$44,914 | -$46,318 | -$63,204 | -$43,734 |